Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | EVP, Operations | July 27, 2012 | July 31, 2012 |
| Stevanato Group S.p.A.STVN · Entity 3826 | Director | March 18, 2026 | March 18, 2026 |
| XBiotech Inc.XBIT · Entity 7044 | Director | June 19, 2017 | June 23, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date July 27, 2012 · Filed July 31, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,608 |
Reported balance
After 2012-07-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2012-07-27 · Exercise / conversion · Acquired 42,109 · Balance 115,608 |
| Common StockSEC Table I · non-derivative | Direct | 157,510 |
Reported balance
After 2012-07-27 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2012-07-27 · Exercise / conversion · Acquired 41,902 · Balance 157,510 |
| Common StockSEC Table I · non-derivative | Direct | 187,510 |
Reported balance
After 2012-07-27 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2012-07-27 · Exercise / conversion · Acquired 30,000 · Balance 187,510 |
| Common StockSEC Table I · non-derivative | Direct | 271,510 |
Reported balance
After 2012-07-27 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2012-07-27 · Exercise / conversion · Acquired 84,000 · Balance 271,510 |
| Common StockSEC Table I · non-derivative | Direct | 334,510 |
Reported balance
After 2012-07-27 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2012-07-27 · Exercise / conversion · Acquired 63,000 · Balance 334,510 |
| Common StockSEC Table I · non-derivative | Direct | 376,510 |
Reported balance
After 2012-07-27 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2012-07-27 · Exercise / conversion · Acquired 42,000 · Balance 376,510 |
| Common StockSEC Table I · non-derivative | Direct | 73,499 |
Reported balance
After 2012-07-27 transaction · row 8
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 8 · 2012-07-27 · Gift · Disposed 303,011 · Balance 73,499 F1: These shares are being transferred to the reporting person's Family Trust. F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3: These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 363,639 |
Reported balance
After 2012-07-27 transaction · row 7
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 7 · 2012-07-27 · Gift · Acquired 303,011 · Balance 363,639 F1: These shares are being transferred to the reporting person's Family Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 60,628 |
Reported balance
After 2012-07-27 transaction · row 9
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 9 · 2012-07-27 · Sale · Disposed 303,011 · Balance 60,628 F4: The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 48,491 |
Reported balance
After 2012-07-30 transaction · row 10
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 10 · 2012-07-30 · Sale · Disposed 12,137 · Balance 48,491 F5: The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.88 · Expires 2013-04-03 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2012-07-27 · Exercise / conversion · Disposed 42,109 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.55 · Expires 2014-04-26 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2012-07-27 · Exercise / conversion · Disposed 41,902 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.79 · Expires 2014-10-29 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2012-07-27 · Exercise / conversion · Disposed 30,000 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.13 · Expires 2015-04-29 | Direct | 0 |
Reported balance
After 2012-07-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2012-07-27 · Exercise / conversion · Disposed 84,000 · Balance 0 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.44 · Expires 2016-04-28 | Direct | 21,000 |
Reported balance
After 2012-07-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2012-07-27 · Exercise / conversion · Disposed 63,000 · Balance 21,000 |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.43 · Expires 2020-04-26 | Direct | 42,000 |
Reported balance
After 2012-07-27 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2012-07-27 · Exercise / conversion · Disposed 42,000 · Balance 42,000 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are being transferred to the reporting person's Family Trust.
F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F3: These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F4: The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
F5: The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
Stevanato Group S.p.A.
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectSecurities owned by you as trustee By Self as Co-Trustee for Self and Spouse | 119,700 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 119,700 |
XBiotech Inc.
Report date June 19, 2017 · Filed June 23, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.24 · Expires 2027-06-19 | Direct | 50,000 |
Reported balance
After 2017-06-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-19 · Exercise / conversion · Acquired 50,000 · Balance 50,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 25, 2011 Filed Apr 28, 2011 01:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 55,125 | $54.69 Strike: $54.69 | $3,014,786.25 |
DisclosureSEC source: 0001127602-11-013880 · form4.xml · derivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,125 Underlying: Common Stock · 55,125 shares Expires 2021-04-25 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 01:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 15,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013880 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,800 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 14, 2011 Filed Mar 15, 2011 22:21 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 9,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-010280 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 69,265 F1 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| March 14, 2011 Filed Mar 15, 2011 22:21 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 9,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-010280 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 F1 · kind: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/26/2011; and 40,000 RSUs which vest fully on 12/31/2013. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 11, 2011 Filed Mar 15, 2011 22:21 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 8,034 | $51.84 | $416,482.56 |
DisclosureSEC source: 0001127602-11-010280 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,486 Read SEC document |
| March 02, 2011 Filed Mar 5, 2011 00:26 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 17,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-009087 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,520 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/26/2011; and 40,000 RSUs which vest fully on 12/31/2013. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:50 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012670 · form4.xml · nonDerivative · entry 6 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 59,779 Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:50 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012670 · form4.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,000 F2 · shares: Shares are being transferred to the Reporting Person's Family Trust. F3 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/29/2011; 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/28/2011; 12,000 RSUs which vest in four equal installments of 3,000 each commencing 4/26/2011; and 40,000 RSUs which vest fully on 12/31/2013. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 29, 2010 Filed Apr 30, 2010 22:50 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,357 | $58.18 | $78,950.26 |
DisclosureSEC source: 0001127602-10-012670 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,643 Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:50 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012670 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 58,136 Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:50 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012670 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 F1 · shares: Shares are being transferred to the Reporting Person's Family Trust. Read SEC document |
| April 28, 2010 Filed Apr 30, 2010 22:50 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,357 | $57.84 | $78,488.88 |
DisclosureSEC source: 0001127602-10-012670 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,643 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:14 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 84,000 | $58.43 Strike: $58.43 | $4,908,120.00 |
DisclosureSEC source: 0001127602-10-012242 · form4.xml · derivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2020-04-26 F4 · derivative.exercise_date: These options are exercisable in four equal annual installments of 25% each commencing 04/26/2011. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:14 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012242 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,000 F2 · shares: The RSUs were granted pursuant to the Company's 2009 Equity Incentive Plan and fully vest on December 31, 2013. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing 4/28/2010; 12,000 RSUs which vest in four equal annual installments of 3,000 each commencing on 4/26/2011; and 40,000 RSUs which vest fully on 12/31/13. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 19:14 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012242 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,000 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest in four equal annual installments of 25% each commencing April 26, 2011. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 21:45 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 4,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-008844 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 56,493 F1 · kind: These shares are being transferred to the reporting person's Family Trust. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 21:45 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 4,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-008844 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 F1 · kind: These shares are being transferred to the reporting person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 21:45 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 3,788 | $57.49 | $217,772.12 |
DisclosureSEC source: 0001127602-10-008844 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,459 Read SEC document |
| March 12, 2010 Filed Mar 16, 2010 21:45 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 8,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-008844 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,247 Read SEC document |
| November 23, 2009 Filed Nov 24, 2009 00:24 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,300 | $56.01 | $72,813.00 |
DisclosureSEC source: 0001127602-09-023455 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 52,034 Read SEC document |
| November 23, 2009 Filed Nov 24, 2009 00:24 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,051 | $56.01 | $226,900.56 |
DisclosureSEC source: 0001127602-09-023455 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 53,334 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 300 | $53.98 | $16,192.50 |
DisclosureSEC source: 0001127602-09-022053 · form4.xml · nonDerivative · entry 8 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 57,385 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 842 | $53.97 | $45,442.74 |
DisclosureSEC source: 0001127602-09-022053 · form4.xml · nonDerivative · entry 7 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 57,685 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 552 | $53.96 | $29,785.92 |
DisclosureSEC source: 0001127602-09-022053 · form4.xml · nonDerivative · entry 6 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 58,527 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 100 | $53.96 | $5,395.50 |
DisclosureSEC source: 0001127602-09-022053 · form4.xml · nonDerivative · entry 5 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 59,079 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 2,200 | $53.95 | $118,690.00 |
DisclosureSEC source: 0001127602-09-022053 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 59,179 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,300 | $53.94 | $70,122.00 |
DisclosureSEC source: 0001127602-09-022053 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 61,379 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,100 | $53.93 | $59,323.00 |
DisclosureSEC source: 0001127602-09-022053 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 62,679 Read SEC document |
| November 05, 2009 Filed Nov 7, 2009 00:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,960 | $53.92 | $267,443.20 |
DisclosureSEC source: 0001127602-09-022053 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 63,779 Read SEC document |
| May 08, 2009 Filed May 8, 2009 22:49 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 6,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-011044 · form4.xml · nonDerivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 68,739 F3 · kind: Shares are being transferred to the Reporting Person's Family Trust. Read SEC document |
| May 08, 2009 Filed May 8, 2009 22:49 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 6,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-011044 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 F1 · kind: Shares are being transferred to the Reporting Person's Family Trust. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| May 08, 2009 Filed May 8, 2009 22:49 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 5,881 | $47.63 | $280,112.03 |
DisclosureSEC source: 0001127602-09-011044 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,973 Read SEC document |
| May 07, 2009 Filed May 8, 2009 22:49 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-011044 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,854 Read SEC document |
| April 29, 2009 Filed May 1, 2009 22:42 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010325 · form4.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 61,766 F3 · kind: Shares are being transferred to the Reporting Person's Family Trust. Read SEC document |
| April 29, 2009 Filed May 1, 2009 22:42 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010325 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 F2 · kind: Shares are being transferred to the Reporting Person's Family Trust. Read SEC document |
| April 29, 2009 Filed May 1, 2009 22:42 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,329 | $50.44 | $67,034.76 |
DisclosureSEC source: 0001127602-09-010325 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,671 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's Amended and Restated 1991 Equity Incentive Plan: 9,000 RSUs which vest in three equal annual installments of 3,000 each commencing 4/29/2010; and 12,000 RSUs which vests in four equal annual installments of 3,000 each commencing 4/29/2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 16:09 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-09-010038 · form4.xml · derivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2016-04-28 F3 · derivative.exercise_date: These shares are exercisable in four equal annual installments of 25% each commencing 04/28/2010. Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 16:09 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010038 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan (the "1991 Plan"). RSUs vest in four equal annual installments of 25% each commence April 28, 2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person. Read SEC document |
| December 03, 2008 Filed Dec 4, 2008 18:58 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 32,393 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001127602-08-010604 · form4.xml · derivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,393 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2008 Filed Dec 4, 2008 18:58 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 32.393 | $56.05 | $1,815.79 |
DisclosureSEC source: 0001127602-08-010604 · form4.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,360.607 F1 · price: The sale price is an average sale price with a low of $56.04 per share and a high of $56.08 per share. A detailed list of the number of shares sold and the sale price of each share is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| December 03, 2008 Filed Dec 4, 2008 18:58 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 32,393 | $38.36 | $1,242,595.48 |
DisclosureSEC source: 0001127602-08-010604 · form4.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2008 Filed Jan 12, 2009 23:46 UTC Amendment | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 32,393 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001127602-09-001052 · form4a.xml · derivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,393 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was exercisable in four annual installments commencing July 1, 2003 and is now fully exercisable. Read SEC document |
| December 03, 2008 Filed Jan 12, 2009 23:46 UTC Amendment | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 32,393 | $38.36 | $1,242,595.48 |
DisclosureSEC source: 0001127602-09-001052 · form4a.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2008 Filed Jan 12, 2009 23:46 UTC Amendment | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 32,393 | $56.05 | $1,815,786.38 |
DisclosureSEC source: 0001127602-09-001052 · form4a.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F2 · shares: This amendment amends the number of shares sold which was originally reported as 32.393. F3 · price: The sale price is an average sale price with a low of $56.04 per share and a high of $56.08 per share. A detailed list of the number of shares sold and the sale price of each share is available upon request by the SEC staff, the issuer of a security holder of the issuer. F4 · balance_after: Represents Restricted Stock Units (RSUs) granted pursuant to the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest in four equal annual installments of 25% each commencing on April 29, 2009. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the executive officer. Read SEC document |
| October 30, 2008 Filed Oct 30, 2008 21:01 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionIso (Right to Buy) · Derivative | 2,607 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-08-058992 · rrd221866.xml · derivative · entry 4 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,607 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2008 Filed Oct 30, 2008 21:01 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 2,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-058992 · rrd221866.xml · nonDerivative · entry 3 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 60,095 F2 · kind: Shares are being transferred to the Reporting Person's Trust. Read SEC document |
| October 30, 2008 Filed Oct 30, 2008 21:01 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 2,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-058992 · rrd221866.xml · nonDerivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · kind: Shares are being transferred to the Reporting Person's Trust. Read SEC document |
| October 30, 2008 Filed Oct 30, 2008 21:01 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,607 | $38.36 | $100,004.52 |
DisclosureSEC source: 0001181431-08-058992 · rrd221866.xml · nonDerivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 200 | $56.25 | $11,250.00 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 14 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,758 Read SEC document |
| October 23, 2008 Filed Oct 27, 2008 23:37 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,421 | $56.24 | $304,877.04 |
DisclosureSEC source: 0001181431-08-058426 · rrd221584.xml · nonDerivative · entry 13 BONANNI FABRIZIO · CIK 0001183903 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,958 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.